KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG/CLDN6 signaling in epithelial ovarian cancer.
Paclitaxel (PTX) resistance contributes to mortality in epithelial ovarian cancer (EOC). Aerobic...
Read More
Hematology/Oncology
Targeted delivery of exosomal miR-484 reprograms tumor vasculature for chemotherapy sensitization.
The vascular dysfunction of ovarian cancer (OC) contributes to the chemotherapeutic resistance. In...
Read More
Prolonged TV Watching Ups Blood Clot Risk
FRIDAY, Jan. 21, 2022 (HealthDay News) — Prolonged television watching increases the risk...
Read More
Biosimilars Could Cut Spending for Biologic Therapy in the U.S.
FRIDAY, Jan. 21, 2022 (HealthDay News) — Biosimilar drugs could drive down prices for...
Read More
Nomogram May Help Predict Survival in Primary Intestinal NHL
THURSDAY, Jan. 20, 2022 (HealthDay News) — A nomogram can assist clinicians in predicting...
Read More
Long-Term Outcomes Described for Survivors of Childhood ALL
TURSDAY, Jan. 20, 2022 (HealthDay News) — In an article published online Dec. 29 in Cancers,...
Read More
Breast Cancer Survivors Face Higher Risk for Hypertension, Diabetes
THURSDAY, Jan. 20, 2022 (HealthDay News) — Women with, versus without, a history of breast...
Read More
2021 USPSTF Lung Cancer Screening Criteria Expand Eligibility
WEDNESDAY, Jan. 19, 2022 (HealthDay News) — The 2021 U.S. Preventive Services Task Force...
Read More
Survival Increase Seen for Adults With Relapsed Ph+ ALL
TUESDAY, Jan. 18, 2022 (HealthDay News) — Real-world data show steady improvement in overall...
Read More
Global Burden of Chronic Lymphocytic Leukemia Up From 1990 to 2019
TUESDAY, Jan. 18, 2022 (HealthDay News) — From 1990 to 2019, the global burden of chronic...
Read More
Guideline Issued for External Beam RT in Primary Liver Cancers
TUESDAY, Jan. 18, 2022 (HealthDay News) — In a clinical practice guideline issued by the...
Read More
Advocating for equitable management of hereditary cancer syndromes.
The potential for preventive medicine to lead to more equitable health outcomes exists with the...
Read More
Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches.
Dysregulation of the discoidin domain receptor (DDR1), a collagen-activated receptor tyrosine...
Read More
Data Support Lowering Age for CRC Screening to 45 Years
FRIDAY, Jan. 14, 2022 (HealthDay News) — The prevalence of colorectal neoplasia observed...
Read More
Overall Breast Cancer Incidence Decreased From 1999 to 2018
THURSDAY, Jan. 13, 2022 (HealthDay News) — The incidence of breast cancer decreased overall...
Read More
Dense Breasts, High BMI May Interact to Up Breast Cancer Risk
WEDNESDAY, Jan. 12, 2022 (HealthDay News) — Breast density and body mass index (BMI) may...
Read More
Response to Radiotherapy for Prostate Cancer Better in Black Men
WEDNESDAY, Jan. 12, 2022 (HealthDay News) — Among men with localized prostate cancer...
Read More
Factors at Midlife May Predict Health Trajectory in Women
MONDAY, Jan. 10, 2022 (HealthDay News) — Factors in women at midlife associated with...
Read More
Various Methods to Treat Blood Cancer
Chronic myelogenous leukemia (CML), both myeloid and lymphoid blast-phase CML, and some cases of...
Read More
The Safeness and Effectiveness of Injecting a Higher Uncapped Doses of Drug to Treat Adult Cancer Patients
A heterogeneous group of hematologic malignancies is known as acute lymphoblastic leukemia (ALL)....
Read More